RESI Panel Announcement: Medical Device Investors

By Lucy Parkinson, Senior Research Manager, LSN

Medical technology represents a major segment of life science investment, with $2.7 billion in venture allocations going into devices and diagnostics in 2014.  At LSN, we track over 700 investors who have an interest in development or clinical-stage medical devices.  For RESI San Francisco, LSN has gathered a panel of experienced medical device investors to share their expertise and advice with medtech entrepreneurs.

Moderated by David Cassak, Managing Partner, Innovation In Medtech, our panelists are:

• Paul Grand, Managing Director, Research Corporation Technologies
• Randy Scott, Partner, HealthQuest Capital
• Mark Chin, Vice President, Longitude Capital
• Randy Barko, President & CEO, Ximedica

The panel will explore the challenges of raising a financing round in the medical device sector, providing advice for entrepreneurs from early development stages through to commercialization.  These investors will explain what makes a device startup stand out, and how they assess the potential risks of a device opportunity.  If you’d like to join us at RESI, register now.

Tags: announcement, Investors, medical device, panel, RESI